The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- 1 Centre for Brain and Mental Health, University of Newcastle, Newcastle, NSW
- 2 University of Newcastle, Newcastle, NSW
- 3 James Cook University, Cairns, QLD
Correspondence: Yael.BarZeev@uon.edu.au
Acknowledgements:
Yael Bar-Zeev thanks the Hunter Cancer Research Alliance Implementation Flagship program for funding her PhD scholarship.
Competing interests:
Yael Bar-Zeev has received fees for lectures in the past (2012–2015) from Novartis NCH, which distributes NRT in Israel.
- 1. Australian Institute of Health and Welfare. Australia’s mothers and babies 2014 — in brief (AIHW Cat No. PER 87; Perinatal Statistics Series No. 32). Canberra: AIHW; 2016.
- 2. Fiore MC, Jaén CR, Baker TB, et al. Treating tobacco use and dependence: 2008 update. Clinical practice guideline. Rockville, MD: US Department of Health and Human Services. Public Health Service; 2008. https://bphc.hrsa.gov/buckets/treatingtobacco.pdf (accessed May 2017).
- 3. Chamberlain C, O’Mara-Eves A, Porter J. Psychosocial interventions for supporting women to stop smoking in pregnancy. Cochrane Database Syst Rev 2017; (2): CD001055.
- 4. Zwar N, Richmond R, Borland R, et al. Supporting smoking cessation: a guide for health professionals [website]. Melbourne: RACGP; 2011 (updated July 2014). http://www.racgp.org.au/your-practice/guidelines/smoking-cessation (accessed May 2017).
- 5. Stead LF, Perera R, Bullen C, et al. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev 2012; (11): CD000146.
- 6. Luck W, Nau H, Hansen R, Steldinger R. Extent of nicotine and cotinine transfer to the human fetus, placenta and amniotic fluid of smoking mothers. Dev Pharmacol Ther 1985; 8: 384-395.
- 7. Bar-Zeev Y, Bonevski B, Twyman L, et al. Opportunities missed: a cross-sectional survey of the provision of smoking cessation care to pregnant women by Australian general practitioners and obstetricians. Nicotine Tob Res 2017; 19: 636-641.
- 8. Herbert R, Coleman T, Britton J. UK general practitioners’ beliefs, attitudes, and reported prescribing of nicotine replacement therapy in pregnancy. Nicotine Tob Res 2005; 7: 541-546.
- 9. Glover M, Paynter J, Bullen C, Kristensen K. Supporting pregnant women to quit smoking: postal survey of New Zealand general practitioners and midwives’ smoking cessation knowledge and practices. N Z Med J 2008; 121: 53-65.
- 10. Price JH, Jordan TR, Dake JA. Perceptions and use of smoking cessation in nurse-midwives’ practice. J Midwifery Womens Health 2006; 51: 208-215.
- 11. National Institute for Health and Care Excellence. Smoking: stopping in pregnancy and after childbirth. London: NICE; 2010. https://www.nice.org.uk/guidance/ph26/resources/smoking-stopping-in-pregnancy-and-after-childbirth-pdf-1996240366789 (accessed May 2017).
- 12. Ministry of Health. Background and recommendations of the New Zealand guidelines for helping people to stop smoking. Wellington, New Zealand: Ministry of Health; 2014. https://www.health.govt.nz/system/files/documents/publications/background-recommendations-new-zealand-guidelines-for-helping-stop-smoking-mar15-v2.pdf (accessed May 2017).
- 13. Canadian Action Network for the Advancement, Dissemination and adoption of practice-informed tobacco treatment. Canadian smoking cessation clinical practice guideline. Toronto, Canada: CAN-ADAPTT; 2011. https://www.peelregion.ca/health/professionals/events/pdf/2013/canadaptt-summary-statements.pdf (accessed May 2017).
- 14. Royal Australian and New Zealand College of Obstetricians and Gynaecologists. Women and smoking. Sydney: RANZCOG; 2014. www.ranzcog.edu.au/RANZCOG_SITE/media/RANZCOG-MEDIA/Women%27s%20Health/Statement%20and%20guidelines/Clinical-Obstetrics/Women-and-Smoking-(C-Obs-53)-Review-November-2014.pdf?ext=.pdf (accessed May 2017).
- 15. Siu AL, US Preventive Services Task Force. Behavioral and pharmacotherapy interventions for tobacco smoking cessation in adults, including pregnant women: US Preventive Services Task Force recommendation statement. Ann Intern Med 2015; 163: 622-634.
- 16. American College of Obstetricians and Gynecologists. Committee opinion no. 471: smoking cessation during pregnancy. Obstet Gynecol 2010; 116: 1241-1244.
- 17. World Health Organization. WHO recommendations for the prevention and management of tobacco use and second-hand smoke exposure in pregnancy. WHO; 2013. http://www.who.int/tobacco/publications/pregnancy/guidelinestobaccosmokeexposure/en (accessed May 2017).
- 18. England LJ, Aagaard K, Bloch M, et al. Developmental toxicity of nicotine: a transdisciplinary synthesis and implications for emerging tobacco products. Neurosci Biobehav Rev 2017; 72: 176-189.
- 19. US Department of Health and Human Services, Office of the Surgeon General. The health consequences of smoking — 50 years of progress: a report of the Surgeon General. Rockville, MD: US Department of Health and Human Services. Public Health Service; 2014. https://www.surgeongeneral.gov/library/reports/50-years-of-progress/full-report.pdf (accessed May 2017).
- 20. Smith AM, Dwoskin LP, Pauly JR. Early exposure to nicotine during critical periods of brain development: mechanisms and consequences. J Pediatr Biochem 2010; 1: 125-141.
- 21. Slotkin TA. If nicotine is a developmental neurotoxicant in animal studies, dare we recommend nicotine replacement therapy in pregnant women and adolescents? Neurotoxicol Teratol 2008; 30: 1-19.
- 22. England LJ, Bunnell RE, Pechacek TF, et al. Nicotine and the developing human: a neglected element in the electronic cigarette debate. Am J Prev Med 2015; 49: 286-293.
- 23. Sekhon HS, Keller JA, Benowitz NL, Spindel ER. Prenatal nicotine exposure alters pulmonary function in newborn rhesus monkeys. Am J Respir Crit Care Med 2001; 164: 989-994.
- 24. Sekhon HS, Keller JA, Proskocil BJ, et al. Maternal nicotine exposure upregulates collagen gene expression in fetal monkey lung. Association with alpha7 nicotinic acetylcholine receptors. Am J Respir Cell Mol Biol 2002; 26: 31-41.
- 25. Holbrook BD. The effects of nicotine on human fetal development. Birth Defects Res C Embryo Today 2016; 108: 181-192.
- 26. Spindel ER, McEvoy CT. The role of nicotine in the effects of maternal smoking during pregnancy on lung development and childhood respiratory disease. implications for dangers of e-cigarettes. Am J Respir Crit Care Med 2016; 193: 486-494.
- 27. Wongtrakool C, Wang N, Hyde DM, et al. Prenatal nicotine exposure alters lung function and airway geometry through α7 nicotinic receptors. Am J Respir Cell Mol Biol 2012; 46: 695-702.
- 28. Shanks N, Greek R, Greek J. Are animal models predictive for humans? Philos Ethics Humanit Med 2009; 4: 2.
- 29. Dhalwani NN, Szatkowski L, Coleman T, et al. Nicotine replacement therapy in pregnancy and major congenital anomalies in offspring. Pediatrics 2015; 135: 859-867.
- 30. Morales-Suárez-Varela MM, Bille C, Christensen K, et al. Smoking habits, nicotine use, and congenital malformations. Obstet Gynecol 2006; 107: 51-57.
- 31. Strandberg-Larsen K, Tinggaard M, Nybo Andersen AM, et al. Use of nicotine replacement therapy during pregnancy and stillbirth: a cohort study. BJOG 2008; 115: 1405-1410.
- 32. Lassen TH, Madsen M, Skovgaard LT, et al. Maternal use of nicotine replacement therapy during pregnancy and offspring birthweight: a study within the Danish National Birth Cohort. Paediatr Perinat Epidemiol 2010; 24: 272-281.
- 33. Brose LS, McEwen A, West R. Association between nicotine replacement therapy use in pregnancy and smoking cessation. Drug Alcohol Depend 2013; 132: 660-664.
- 34. Coleman T, Cooper S, Thornton JG, et al. A randomized trial of nicotine-replacement therapy patches in pregnancy. N Engl J Med 2012; 366: 808-818.
- 35. Berlin I, Grangé G, Jacob N, Tanguy ML. Nicotine patches in pregnant smokers: randomised, placebo controlled, multicentre trial of efficacy. BMJ 2014; 348: g1622.
- 36. Oncken C, Dornelas E, Greene J, et al. Nicotine gum for pregnant smokers: a randomized controlled trial. Obstet Gynecol 2008; 112: 859-867.
- 37. Kapur B, Hackman R, Selby P, et al. Randomized, double-blind, placebo-controlled trial of nicotine replacement therapy in pregnancy. Curr Ther Res 2001; 62: 274-278.
- 38. Wisborg K, Henriksen TB, Jespersen LB, Secher NJ. Nicotine patches for pregnant smokers: a randomized controlled study. Obstet Gynecol 2000; 96: 967-971.
- 39. El-Mohandes AA, Windsor R, Tan S, et al. A randomized clinical trial of trans-dermal nicotine replacement in pregnant African-American smokers. Matern Child Health J 2013; 17: 897-906.
- 40. Pollak KI, Oncken CA, Lipkus IM, et al. Nicotine replacement and behavioral therapy for smoking cessation in pregnancy. Am J Prev Med 2007; 33: 297-305.
- 41. Hotham ED, Gilbert AL, Atkinson ER. A randomised-controlled pilot study using nicotine patches with pregnant women. Addict Behav 2006; 31: 641-648.
- 42. Coleman T, Chamberlain C, Davey MA, et al. Pharmacological interventions for promoting smoking cessation during pregnancy. Cochrane Database Syst Rev 2015; (12): CD010078.
- 43. Cooper S, Taggar J, Lewis S, et al. Effect of nicotine patches in pregnancy on infant and maternal outcomes at 2 years: follow-up from the randomised, double-blind, placebo-controlled SNAP trial (Erratum in Lancet Respir Med 2014; 2: e22). Lancet Respir Med 2014; 2: 728-737.
- 44. Dempsey D, Jacob P, Benowitz NL. Accelerated metabolism of nicotine and cotinine in pregnant smokers. J Pharmacol Exp Ther 2002; 301: 594-598.
- 45. Mendelsohn C, Gould GS. Nicotine patches in pregnant smokers: randomised, placebo controlled, multicentre trial of efficacy (rapid response letter). BMJ 2014; 348: g1622.
- 46. Bowker KA, Lewis S, Coleman T, et al. Comparison of cotinine levels in pregnant women while smoking and when using nicotine replacement therapy. Nicotine Tob Res 2014; 16: 895-898.
- 47. Bar-Zeev Y, Michelle B, Gould GS. Indigenous Counselling And Nicotine (ICAN) Quit in Pregnancy educational resource package. Callaghan: University of Newcastle University; 2016.
- 48. World Health Organization. Pregnancy and postpartum smoking cessation. In: Gender, women, and the tobacco epidemic. WHO, 2010; pp 175-188. http://www.who.int/tobacco/publications/gender/women_tob_epidemic/en (accessed May 2017).
- 49. Fidler JA, Shahab L, West R. Strength of urges to smoke as a measure of severity of cigarette dependence: comparison with the Fagerstrom Test for Nicotine Dependence and its components. Addiction 2011; 106: 631-638.
- 50. Riaz M, Lewis S, Coleman T, et al. Which measures of cigarette dependence are predictors of smoking cessation during pregnancy? Analysis of data from a randomised controlled trial. Addiction 2016; 111: 1656-1665.
- 51. Bar-Zeev Y, Bonevski B, Bovill M, et al, ICAN QUIT in Pregnancy Pilot Group. The Indigenous Counselling and Nicotine (ICAN) QUIT in Pregnancy Pilot Study protocol: a feasibility step-wedge cluster randomised trial to improve health providers’ management of smoking during pregnancy. BMJ Open 2017; 7: e016095.
- 52. Fahy SJ, Cooper S, Coleman T, et al. Provision of smoking cessation support for pregnant women in England: results from an online survey of NHS stop smoking services for pregnant women. BMC Health Serv Res 2014; 14: 107.
- 53. McGowan A, Hamilton S, Barnett D, et al. “Breathe”: the stop smoking service for pregnant women in Glasgow. Midwifery 2010; 26: e1-e13.
- 54. Grunseit AC, Ding D, Anderson C, et al. A profile of callers to the New South Wales Quitline, Australia, 2008–2011. Nicotine Tob Res 2015; 17: 617-621.
Online responses are no longer available. Please refer to our instructions for authors page for more information.
Summary